AAAAAA
Results: 1-25/40
Authors:
TARTOUR E
GEY A
SASTREGARAU X
SURIN IL
MOSSERI V
FRIDMAN WH
Citation: E. Tartour et al., PROGNOSTIC VALUE OF INTRATUMORAL INTERFERON-GAMMA MESSENGER-RNA EXPRESSION IN INVASIVE CERVICAL CARCINOMAS, Journal of the National Cancer Institute, 90(4), 1998, pp. 287-294
QUANTITATION AND BIOCHEMICAL-CHARACTERIZATION OF THE PLASMATIC FORM OF THE HUMAN SOLUBLE IL-5R-ALPHA
Authors:
MONTEROJULIAN FA
RAMANANARIVO T
TARTOUR E
BRAILLY H
Citation: Fa. Monterojulian et al., QUANTITATION AND BIOCHEMICAL-CHARACTERIZATION OF THE PLASMATIC FORM OF THE HUMAN SOLUBLE IL-5R-ALPHA, European cytokine network, 9(3), 1998, pp. 286-286
Authors:
FRIDMAN WH
TARTOUR E
Citation: Wh. Fridman et E. Tartour, MACROPHAGE-PRODUCED AND LYMPHOCYTE-PRODUCED TH1 AND TH2 CYTOKINES IN THE TUMOR MICROENVIRONMENT, Research in immunology (Paris), 149(7-8), 1998, pp. 651-653
Authors:
LEE RS
TARTOUR E
VANDERBRUGGEN P
VANTOMME V
JOYEUX I
GOUD B
FRIDMAN WH
JOHANNES L
Citation: Rs. Lee et al., MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I PRESENTATION OF EXOGENOUS SOLUBLE TUMOR-ANTIGEN FUSED TO THE B-FRAGMENT OF SHIGA TOXIN, European Journal of Immunology, 28(9), 1998, pp. 2726-2737
Authors:
BERGER A
PIQUERAS B
PAGES F
TARTOUR E
CUGNENC PH
FRIDMAN WH
Citation: A. Berger et al., FAS, FAS LIGAND, IMMUNE TOLERANCE AND CAN CER - INVOLVEMENT IN COLON-CANCER, Bulletin du cancer, 85(2), 1998, pp. 129-133
Authors:
FRIDMAN WH
BERGER A
LEE RS
TARTOUR E
Citation: Wh. Fridman et al., TUMOR IMMUNOLOGY, Bulletin du cancer, 85(1), 1998, pp. 29-30
Authors:
MICHON JM
GEY A
MOUTEL S
TARTOUR E
MERESSE V
FRIDMAN W
TEILLAUD JL
Citation: Jm. Michon et al., IN-VIVO INDUCTION OF FUNCTIONAL FC-GAMMA-RI (CD64) ON NEUTROPHILS ANDMODULATION OF BLOOD CYTOKINE MESSENGER-RNA LEVELS IN CANCER-PATIENTS TREATED WITH G-CSF (RMETHUG-CSF), British Journal of Haematology, 100(3), 1998, pp. 550-556
Authors:
FRIDMAN WH
TARTOUR E
Citation: Wh. Fridman et E. Tartour, THE USE OF CYTOKINES IN THE TREATMENT OF SOLID TUMORS, HEM CELL TH, 39(2), 1997, pp. 105-108
Authors:
FRIDMAN WH
BERGER A
CUGNENC PH
TARTOUR E
Citation: Wh. Fridman et al., CYTOKINES AS PROGNOSTIC AND THERAPEUTIC TOOLS IN HUMAN CANCER, European cytokine network, 8(3), 1997, pp. 321-322
Authors:
MONTEROJULIAN FA
BRAILLY H
SAUTES C
JOYEUX I
DORVAL T
MOSSERI V
YASUKAWA K
WIJDENES J
ADLER A
GORIN I
FRIDMAN WH
TARTOUR E
Citation: Fa. Monterojulian et al., CHARACTERIZATION OF SOLUBLE GP130 RELEASED BY MELANOMA CELL-LINES - APOLYVALENT ANTAGONIST OF CYTOKINES FROM THE INTERLEUKIN-6 FAMILY, Clinical cancer research, 3(8), 1997, pp. 1443-1451
Authors:
FRIDMAN WH
PAGES F
LEE RS
MATHIOT C
DORVAL T
THIOUNN N
POUILLART P
DEBRE B
TARTOUR E
Citation: Wh. Fridman et al., CYTOKINE-BASED IMMUNOTHERAPY OF SOLID TUMORS (REVIEW), Oncology Reports, 4, 1997, pp. 235-240
Authors:
THIOUNN N
PAGES F
FLAM T
TARTOUR E
MOSSERI V
ZERBIB M
BEUZEBOC P
DENEUX L
FRIDMAN WH
DEBRE B
Citation: N. Thiounn et al., IL-6 IS A SURVIVAL PROGNOSTIC FACTOR IN RENAL-CELL CARCINOMA, Immunology letters, 58(2), 1997, pp. 121-124
Authors:
TARTOUR E
DENEUX L
MOSSERI V
JAULERRY C
BRUNIN F
POINT D
VALIDIRE P
DUBRAY B
FRIDMAN WH
RODRIGUEZ J
Citation: E. Tartour et al., SOLUBLE INTERLEUKIN-2 RECEPTOR SERUM LEVEL AS A PREDICTOR OF LOCOREGIONAL CONTROL AND SURVIVAL FOR PATIENTS WITH HEAD AND NECK-CARCINOMA - RESULTS OF A MULTIVARIATE PROSPECTIVE-STUDY, Cancer, 79(7), 1997, pp. 1401-1408
Authors:
LEE RS
SCHLUMBERGER M
CAILLOU B
PAGES F
FRIDMAN WH
TARTOUR E
Citation: Rs. Lee et al., PHENOTYPIC AND FUNCTIONAL-CHARACTERIZATION OF TUMOR-INFILTRATING LYMPHOCYTES DERIVED FROM THYROID-TUMORS, European journal of cancer, 32A(7), 1996, pp. 1233-1239
Authors:
TARTOUR E
DORVAL T
LEE RS
FRIDMAN WH
Citation: E. Tartour et al., IMMUNOTHERAPY IN THE TREATMENT OF CANCER, La Presse medicale, 25(35), 1996, pp. 1717-1722
Authors:
TARTOUR E
BLAY JY
DORVAL T
ESCUDIER B
MOSSERI V
DOUILLARD JY
DENEUX L
GORIN I
NEGRIER S
MATHIOT C
POUILLART P
FRIDMAN WH
Citation: E. Tartour et al., PREDICTORS OF CLINICAL-RESPONSE TO INTERLEUKIN-2-BASED IMMUNOTHERAPY IN MELANOMA PATIENTS - A FRENCH MULTIINSTITUTIONAL STUDY, Journal of clinical oncology, 14(5), 1996, pp. 1697-1703
Authors:
SASTREGARAU X
LOSTE MN
VINCENTSALOMON A
FAVRE M
MOURET E
DELAROCHEFORDIERE A
DURAND JC
TARTOUR E
LEPAGE V
CHARRON D
Citation: X. Sastregarau et al., DECREASED FREQUENCY OF HLA-DRB1-ASTERISK-13 ALLELES IN FRENCHWOMEN WITH HPV-POSITIVE CARCINOMA OF THE CERVIX, International journal of cancer, 69(3), 1996, pp. 159-164
Authors:
MATHIOT C
MARY JY
TARTOUR E
FACON T
MONCONDUIT M
GROSBOIS B
POLLET JP
MICHAUX JL
ZIEGLER LE
SAUTES C
BATAILLE R
FRIDMAN WH
Citation: C. Mathiot et al., SOLUBLE CD16 (SCD16), A MARKER OF MALIGNANCY IN INDIVIDUALS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS), British Journal of Haematology, 95(4), 1996, pp. 660-665
Authors:
CANQUE B
ROSENZWAJG M
GEY A
TARTOUR E
FRIDMAN WH
GLUCKMAN JC
Citation: B. Canque et al., MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA IS INDUCED BY HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION OF MONOCYTE-DERIVED MACROPHAGES, Blood, 87(5), 1996, pp. 2011-2019
Authors:
MATHIOT C
THIOUNN N
TARTOUR E
FLAM T
PEYRET C
JOYEUX I
ZERBIB M
BRANDELY M
DEBRE B
FRIDMAN WH
Citation: C. Mathiot et al., NONCYTOTOXIC CD4 TUMOR-INFILTRATING LYMPHOCYTES INDUCE RESPONSES IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA PREVIOUSLY TREATED WITH INTERLEUKIN-2, European journal of cancer, 31A(9), 1995, pp. 1551-1552
Authors:
CLAVE E
SOCIE G
COSSET JM
CHAILLET MP
TARTOUR E
GIRINSKY T
CAROSELLA E
FRIDMAN H
GLUCKMAN E
MATHIOT C
Citation: E. Clave et al., MULTICOLOR FLOW-CYTOMETRY ANALYSIS OF BLOOD-CELL SUBSETS IN PATIENTS GIVEN TOTAL-BODY IRRADIATION BEFORE BONE-MARROW TRANSPLANTATION, International journal of radiation oncology, biology, physics, 33(4), 1995, pp. 881-886
Authors:
TARTOUR E
PANNETIER C
MATHIOT C
TEILLAUD JL
SAUTES C
KOURILSKY P
FRIDMAN WH
Citation: E. Tartour et al., PROGNOSTIC VALUE OF CYTOKINE AND SOLUBLE FC-GAMMA RECEPTOR ASSAYS IN ONCOLOGY, Immunology letters, 44(2-3), 1995, pp. 145-148
Authors:
BOUCHARD C
GALINHA A
TARTOUR E
FRIDMAN WH
SAUTES C
Citation: C. Bouchard et al., A TRANSFORMING-GROWTH-FACTOR-BETA-LIKE IMMUNOSUPPRESSIVE FACTOR IN IMMUNOGLOBULIN-G-BINDING FACTOR, The Journal of experimental medicine, 182(6), 1995, pp. 1717-1726
Authors:
TARTOUR E
LATOUR S
MATHIOT C
THIOUNN N
MOSSERI V
JOYEUX I
DENGHIEN CD
LEE RS
DEBRE B
FRIDMAN WH
Citation: E. Tartour et al., VARIABLE EXPRESSION OF CD3-ZETA CHAIN IN TUMOR-INFILTRATING LYMPHOCYTES (TIL) DERIVED FROM RENAL-CELL CARCINOMA - RELATIONSHIP WITH TIL PHENOTYPE AND FUNCTION, International journal of cancer, 63(2), 1995, pp. 205-212
Authors:
FRIDMAN WH
MATHIOT C
TARTOUR E
DORVAL T
THIOUNN N
POUILLART P
DEBRE B
Citation: Wh. Fridman et al., CELLULAR THERAPIES IN CANCER, Bulletin du cancer, 82(3), 1995, pp. 235-236